Laboratorios Farmaceuticos Rovi SA
Company Profile
Business description
Laboratorios Farmaceuticos Rovi SA is engaged in the production and sale of pharmaceutical products, including products developed in-house. Its activities include the sale of its own pharmaceutical products, the distribution of products under licences granted by other laboratories, and the provision of manufacturing services to third parties. Its operating segments are Manufacturing, which generates the maximum revenue from service contracts related to the finalisation of pharmaceutical product production processes for external entities and the manufacture of products to be marketed by other group companies, Marketing, and Other. It operates in Spain, the European Union, and other countries.
Contact
Calle Julian Camarillo, 35
Madrid28037
ESPT: +34 913756230
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
2,232
Stocks News & Analysis
stocks
Fears of deteriorating loan quality sends bank share plummeting
stocks
Why it’s not all bad news for Flight Centre following downgrade
stocks
Chart of the Week: What 650 IPOs reveal about long-term performance
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,964.20 | 1.20 | -0.01% |
| CAC 40 | 8,384.87 | 46.74 | -0.55% |
| DAX 40 | 24,671.22 | 323.61 | -1.29% |
| Dow JONES (US) | 51,876.11 | 44.51 | -0.09% |
| FTSE 100 | 10,508.02 | 21.87 | -0.21% |
| HKSE | 22,671.86 | 405.05 | -1.76% |
| NASDAQ | 25,297.62 | 60.99 | -0.24% |
| Nikkei 225 | 69,360.88 | 3,005.46 | -4.15% |
| NZX 50 Index | 13,495.24 | 2.19 | 0.02% |
| S&P 500 | 7,354.02 | 3.47 | -0.05% |
| S&P/ASX 200 | 8,764.20 | 0.20 | 0.00% |
| SSE Composite Index | 4,027.26 | 93.02 | -2.26% |